Ischemic heart disease Board decisions

The Board granted an initial rating of 30 percent for cardiomyopathy and heart murmur with coronary artery disease, denied a compensable rating for hypertension, and denied an increased rating for degenerative arthritis and degenerative disc disease of the lumbar spine.

The Board remands the claims for service connection for heart disability, diabetes mellitus, type II, and bilateral eye disabilities due to inadequate medical opinions regarding their relationship to toxic exposure during active duty.

The Board remands the claims for service connection for coronary artery disease and prostate cancer, to include as due to herbicide exposure or a medically unexplained chronic multi-symptom illness (MUCMI), for further development of the record.

The Board remands the claims for service connection for a heart disorder and sleep disorder due to pre-decisional duty to assist errors.

The Board remands the matters for further development, including obtaining potentially relevant medical records and readjudicating the claims.

The Board remands the claim for service connection for a heart disability for initial AOJ consideration on the merits, as new and relevant evidence has been received since the December 2018 rating decision.

The Board remands the claims for service connection for coronary artery disease, bilateral osteopenia, and polymyalgia rheumatica due to inadequate VA examination reports.

The Board remands the claims for a left hip disability, COPD, and heart disease to correct duty-to-assist errors related to medical examinations and asbestos exposure.

The appeal for service connection for an anxiety disorder was dismissed, and the appeals for service connection for Parkinson's disease, a respiratory condition (COPD), a heart disability (coronary artery disease), rhinitis, diabetes mellitus, type II (diabetes), right lower extremity diabetic peripheral neuropathy, left lower extremity diabetic peripheral neuropathy, and right upper extremity diabetic peripheral neuropathy were remanded for further development.

The Board denied the veteran's claims for increased ratings and remanded a claim for TDIU, finding that the evidence did not support higher ratings for his heart disability or hypertension.

The Board granted service connection for valvular heart disease and persistent postural-perceptual dizziness, but remanded the claims for residuals of bladder cancer and a prostate condition.

The Board granted service connection for a heart disability and sleep apnea, both related to in-service exposure to toxic substances.

The Veteran withdrew his appeals for initial and increased ratings for heart condition and lower extremity radiculopathy.

The Board denied service connection for heart, hypertension, diabetes, insomnia, and foot disabilities as the evidence did not show current diagnoses or functional limitations related to these conditions during the appeal period.

The Board remands the matter to obtain a TERA opinion and relevant treatment records as part of the duty to assist.

The Veteran was granted a temporary rating of 100 percent for his heart disability from March 1, 2021 to June 1, 2021, but the claim for an increased rating in excess of 60 percent prior to and after this period was denied.

The Board remands the claims for service connection for a heart disability, to include coronary artery disease, and left ear hearing loss due to inadequate medical opinions.

The appeal for service connection for heart condition, hypertension, low back strain with spondylosis, and exotropia of the left eye was dismissed due to a claims processing defect.

The appeals for service connection for a heart disorder, Parkinson's disease, pulmonary disorder, skin rash, and posttraumatic stress disorder are dismissed due to the Veteran's death during the pendency of the appeal.

The Board granted service connection for diabetes mellitus type II, ischemic heart disease, and hypertension from August 10, 2022, under the PACT Act. The claim for a thyroid disability was denied.